Titer

Titer designates the concentration of biological products in fermentation broths or cell culture media, typically expressing therapeutic protein, antibody, or viral vector quantities per volume unit, serving as critical process parameter reflecting productivity, process performance, and economic viability. This measurement represents cumulative outcome of multiple factors including cell density, specific productivity per cell, culture duration, and product stability, with higher titers generally enabling more economical manufacturing.

The biopharmaceutical industry continuously pursues titer enhancement through cell line engineering, media optimisation, feeding strategies, and process parameter control maximising productivity while maintaining product quality. Cell line development selects high-producing clones, employs gene amplification increasing transgene copies, or engineers cells eliminating bottlenecks. Media formulation optimises nutrient balance, growth factors, and feed composition supporting high cell densities and productivity. Fed-batch processes supply nutrients maintaining optimal conditions throughout extended cultures. Analytics monitor titer throughout culture guiding harvest timing and process adjustments. Economic modelling demonstrates titer impacts on manufacturing costs with higher titers dramatically reducing per-gram production expenses. As understanding improves regarding productivity limiting factors, analytical technologies enable real-time monitoring, and engineering capabilities advance, titer improvements continue through systematic optimisation, novel approaches like continuous processing, and sophisticated control strategies supporting economical biomanufacturing.